Comparative Study of the Mesenchymal Stem Cell and Simvastatin in the Treatment of Hepatic Fibrosis in Rats Induced by Carbon Tetrachloride | ||
| Benha Medical Journal | ||
| Article 192, Volume 39, Special issue (Academic), September and October 2022, Pages 78-95 PDF (1.61 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/bmfj.2021.80486.1426 | ||
| Authors | ||
| Hanan Ibrahim Elkerdasy* 1; Ali Mohamed Ali Mohamed2; Essam Mohammed Elsaid Eid3; marian victor zaki2; Naglaa Ali Saber Sarg4 | ||
| 1anatomy department faculty of medicen benha university | ||
| 2anatomy department, faculty of medicine, benha university | ||
| 3Professor & Head of Anatomy & Embryology ,Department , faculty of medicine, Benha University | ||
| 4Assistant Professor of Anatomy & Embryology, Faculty of medicine , Benha University | ||
| Abstract | ||
| Background: Hepatic fibrosis is an important medical disease with high rates of morbidity and mortality. Bone marrow mesenchymal stem cells have been recommended as a powerful therapy for treatment of liver fibrosis. Simvastatin has an ameliorative effect on fibrosis of different organs. The study aimed at comparing between the effect of BM-MSCs and simvastatin in treatment of liver fibrosisinduced by CCL4. Material and Methods: Fifty rats were categorized into, group I control group, group II in which rats injected by CCl4 to induce hepatic fibrosis. Group III in which rats were injected by CCL4,then injected intravenously by a single dose of BM-MSCs, group IV in which rats were injected by CCL4 then given simvastatin orally once daily for eight weeks. Group V in which rats were given both BM-MSC and simvastatin. At the end of the experimental study, blood samples were collected for biochemical analysis and liver tissues were prepared for histological and immunohistochemical examination. Results: CCL4 significantly elevated liver enzymes and induced destruction of normal hepatic structures with significant elevation of mean area percentage of collagen fibers deposition and TGF-b expression. BM-MSC and simvastatin improved liver enzymes and histological structure of liver tissue, but the anti-fibrotic effect of BM-MSC was superior to that of simvastatin. Moreover, combination of BM-MSC and simvastatin exerted strong anti-fibrotic effect and preserved normal histologic structure of liver tissue more than each of them alone. Conclusion: A combination of BM-MSCs and simvastatin has an ameliorative role in the treatment of liver fibrosis induced by CCl4. | ||
| Keywords | ||
| Liver fibrosis; CCL4; BM-MSCs; simvastatin; TGF b | ||
|
Statistics Article View: 308 PDF Download: 420 |
||
